खोज परिणाम - Christoph Suppan
- प्रदर्शित 1 - 4 परिणाम 4
-
1
Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy द्वारा Christoph Suppan, Vesna Bjelic‐Radisic, Marlen La Garde, Andrea Groselj‐Strele, Katharina Eberhard, Hellmut Samonigg, Hans Loibner, Nadia Dandachi, Marija Balić
प्रकाशित 2015Artigo -
2
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy द्वारा H Müller, Florian Posch, Christoph Suppan, Ute Bargfrieder, Melanie Gumpoldsberger, Robert E. Hammer, Hubert Häuser, Nadia Dandachi, Kurt Prein, Herbert Stoeger, Sigurd Lax, Marija Balić
प्रकाशित 2019Artigo -
3
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance द्वारा Julia Schneider, Najib Ben Khaled, Liangtao Ye, Ralf Wimmer, Linda Hammann, Alexander Weich, Christoph Suppan, Ujjwal Mukund Mahajan, A. W. Jung, Jörg Kumbrink, Gerald Denk, Monika Rau, Volker Kunzmann, Solveig Kuss, Jan Neuman, Julia Mayerle, Andreas Geier, Heike M. Hermanns, Enrico N. De Toni, Florian P. Reiter
प्रकाशित 2025Artigo -
4
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer द्वारा Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler, Guenther G. Steger, Sigrun Greil‐Ressler, Marija Balić, Dietmar Heck, R. Jakesz, Josef Thaler, Daniel Egle, D. Manfreda, Vesna Bjelic‐Radisic, Ursula Wieder, Christian F. Singer, Elisabeth Melbinger‐Zeinitzer, Ferdinand Haslbauer, P. Sevelda, Harald Trapl, Viktor Wette, Kerstin Wimmer, Simon Peter Gampenrieder, Rupert Bartsch, Stephanie Strobl, Christoph Suppan, Christine Brunner, Christine Deutschmann, Lidija Soelkner, Christian Fesl, Richard Greil
प्रकाशित 2021Artigo
खोज साधन:
संबंधित विषय
Breast cancer
Cancer
Internal medicine
Medicine
Oncology
Anthracycline
Confidence interval
Hazard ratio
Subgroup analysis
Surgical oncology
Taxane
Anastrozole
Aromatase
Aromatase inhibitor
Biology
CDKN2A
Cancer research
Cell cycle
Clinical endpoint
Colorectal cancer
Cyclin-dependent kinase
Cyclin-dependent kinase 2
Cyclin-dependent kinase 4
Gynecology
Hormonal therapy
Immunotherapy
Metastasis
Metastatic breast cancer
Multivariate analysis
Neoadjuvant therapy